Anthony Wignall

755 total citations
48 papers, 535 citations indexed

About

Anthony Wignall is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Anthony Wignall has authored 48 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 20 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Anthony Wignall's work include Oral health in cancer treatment (10 papers), Gut microbiota and health (6 papers) and Advanced Drug Delivery Systems (6 papers). Anthony Wignall is often cited by papers focused on Oral health in cancer treatment (10 papers), Gut microbiota and health (6 papers) and Advanced Drug Delivery Systems (6 papers). Anthony Wignall collaborates with scholars based in Australia, United States and New Zealand. Anthony Wignall's co-authors include Clive A. Prestidge, Paul Joyce, Joanne M. Bowen, Dorothy Keefe, Santhni Subramaniam, Nicky Thomas, Emma Bateman, Bronwen J. Mayo, Kate R. Secombe and Thomas Eade and has published in prestigious journals such as Advanced Functional Materials, Journal of Colloid and Interface Science and Journal of Controlled Release.

In The Last Decade

Anthony Wignall

42 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony Wignall Australia 13 152 125 107 81 67 48 535
Caroline Addison Carvalho Xavier de Medeiros Brazil 16 142 0.9× 146 1.2× 84 0.8× 42 0.5× 32 0.5× 32 655
Sok Bee Lim Singapore 12 180 1.2× 63 0.5× 39 0.4× 121 1.5× 48 0.7× 19 683
Marit D Moen New Zealand 15 164 1.1× 74 0.6× 124 1.2× 46 0.6× 52 0.8× 25 759
Menglin Wang China 13 99 0.7× 22 0.2× 99 0.9× 82 1.0× 122 1.8× 38 552
Priya Gupta India 13 160 1.1× 73 0.6× 42 0.4× 18 0.2× 57 0.9× 54 509
Meng Yang China 18 177 1.2× 38 0.3× 102 1.0× 31 0.4× 44 0.7× 50 714
Ba X. Hoang United States 13 125 0.8× 50 0.4× 80 0.7× 13 0.2× 34 0.5× 47 521
Ahmed B. Ibrahim Egypt 16 169 1.1× 59 0.5× 43 0.4× 327 4.0× 26 0.4× 23 602
E. Marttin Netherlands 9 214 1.4× 118 0.9× 15 0.1× 529 6.5× 44 0.7× 12 781

Countries citing papers authored by Anthony Wignall

Since Specialization
Citations

This map shows the geographic impact of Anthony Wignall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Wignall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Wignall more than expected).

Fields of papers citing papers by Anthony Wignall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Wignall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Wignall. The network helps show where Anthony Wignall may publish in the future.

Co-authorship network of co-authors of Anthony Wignall

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Wignall. A scholar is included among the top collaborators of Anthony Wignall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Wignall. Anthony Wignall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wignall, Anthony, Zelalem A. Mekonnen, Benjamin S.‐Y. Ung, et al.. (2025). Microfluidic Optimization of PEI-Lipid Hybrid Nanoparticles for Efficient DNA Delivery and Transgene Expression. Pharmaceutics. 17(4). 454–454.
2.
3.
Wignall, Anthony, et al.. (2024). Enhancing the pharmacokinetics of abiraterone acetate through lipid-based formulations: addressing solubility and food effect challenges. Drug Delivery and Translational Research. 15(11). 3770–3782.
4.
5.
6.
Jambhrunkar, Manasi, et al.. (2023). Mesoporous Organosilica Nanoparticles to Fight Intracellular Staphylococcal Aureus Infections in Macrophages. Pharmaceutics. 15(4). 1037–1037. 4 indexed citations
7.
Subramaniam, Santhni, Anthony Wignall, Alexander Hunter, et al.. (2023). Self-emulsifying drug delivery systems (SEDDS) disrupt the gut microbiota and trigger an intestinal inflammatory response in rats. International Journal of Pharmaceutics. 648. 123614–123614. 25 indexed citations
8.
Subramaniam, Santhni, Paul Joyce, Clifford Young, et al.. (2023). Protein adsorption determines pulmonary cell uptake of lipid-based nanoparticles. Journal of Colloid and Interface Science. 641. 36–47. 28 indexed citations
9.
Kopecki, Zlatko, Timothy J. Barnes, Anthony Wignall, et al.. (2023). Lipid Liquid Crystal Nanoparticles: Promising Photosensitizer Carriers for the Treatment of Infected Cutaneous Wounds. Pharmaceutics. 15(2). 305–305. 4 indexed citations
10.
Bateman, Emma, Paul Joyce, Anthony Wignall, et al.. (2023). Fibre-rich diet attenuates chemotherapy-related neuroinflammation in mice. Brain Behavior and Immunity. 115. 13–25. 11 indexed citations
11.
Secombe, Kate R., et al.. (2022). Antibiotic treatment targeting gram negative bacteria prevents neratinib-induced diarrhea in rats. Neoplasia. 30. 100806–100806. 11 indexed citations
12.
Wignall, Anthony, et al.. (2022). A membrane-free microfluidic approach to mucus permeation for efficient differentiation of mucoadhesive and mucopermeating nanoparticulate systems. Drug Delivery and Translational Research. 13(4). 1088–1101. 12 indexed citations
13.
Secombe, Kate R., et al.. (2020). Pathophysiology of neratinib-induced diarrhea in male and female rats: microbial alterations a potential determinant. Breast Cancer. 28(1). 99–109. 9 indexed citations
14.
Mayo, Bronwen J., Kate R. Secombe, Anthony Wignall, et al.. (2020). The GLP-2 analogue elsiglutide reduces diarrhoea caused by the tyrosine kinase inhibitor lapatinib in rats. Cancer Chemotherapy and Pharmacology. 85(4). 793–803. 20 indexed citations
15.
Jia, Zhengyang, Anthony Wignall, Clive A. Prestidge, & Benjamin Thierry. (2020). An ex vivo investigation of the intestinal uptake and translocation of nanoparticles targeted to Peyer’s patches microfold cells. International Journal of Pharmaceutics. 594. 120167–120167. 14 indexed citations
16.
Secombe, Kate R., Anthony Wignall, John Finnie, et al.. (2018). Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model. Cancer Chemotherapy and Pharmacology. 83(3). 531–543. 11 indexed citations
17.
Mayo, Bronwen J., Emma Bateman, Andrea M. Stringer, et al.. (2014). The new selective glp-2 receptor agonist, elsiglutide, improves irinotecan-induced diarrhoea and mucositis in the rat. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 3 indexed citations
18.
Mayo, Bronwen J., Andrea M. Stringer, Emma Bateman, et al.. (2014). Apoptosis, proliferation and inflammation are improved after treatment with the new selective glp-2 receptor agonist, elsiglutide, in a rat model of irinotecan-induced mucositis. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 1 indexed citations
19.
Patterson, Margaret, Ronald Y. Chin, David Veivers, et al.. (2014). Functional Swallowing Outcomes in Nasopharyngeal Cancer Treated with IMRT at 6 to 42 months Post-Radiotherapy. Dysphagia. 29(6). 663–670. 15 indexed citations
20.
Malhi, Gin S., Danielle Adams, Richard Porter, et al.. (2009). Clinical practice recommendations for depression. Acta Psychiatrica Scandinavica. 119(s439). 8–26. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Addison Carvalho Xavier de Medeiros Breakdown of academic impact, for papers by Sok Bee Lim Breakdown of academic impact, for papers by Marit D Moen Breakdown of academic impact, for papers by Menglin Wang Breakdown of academic impact, for papers by Priya Gupta Breakdown of academic impact, for papers by Meng Yang Breakdown of academic impact, for papers by Ba X. Hoang Breakdown of academic impact, for papers by Ahmed B. Ibrahim Breakdown of academic impact, for papers by E. Marttin
Rankless by CCL
2026